A prospective evaluation of community acquired gastroenteritis in paediatric practices: impact and disease burden of rotavirus infection

AIMS To examine the disease burden and epidemiology of community acquired rotavirus gastroenteritis in Austrian children treated in a paediatric practice. METHODS A prospective, population based, multicentre study in four paediatric practices and two children's hospitals (Innsbruck and Leoben). Children ⩽ 48 months of age presenting with gastroenteritis during a six month period of rotavirus peak between December 1997 and May 1998 were included. Prospective testing of stool samples for rotavirus was performed using ELISA. RESULTS A total of 6969 children were enrolled; 171 (2.4%) had community acquired gastroenteritis. Of 144 children who could be included in further analysis, 49 (34%; median age 16.7 months) were rotavirus positive, and 95 (66%; median age 17.0 months) were rotavirus negative. Three of the rotavirus positive children (median age 14.6 months) were hospitalised. The severity of rotavirus positive gastroenteritis was significantly higher than that of rotavirus negative gastroenteritis. The incidence of community acquired gastroenteritis was 4.67 per 100 children per year, and of rotavirus positive gastroenteritis 1.33 per 100 children per year. CONCLUSION Rotavirus is a relevant cause of community acquired gastroenteritis in children aged 4 years and younger treated by a paediatrician. The data can be used as a basis for developing strategies to prevent infection.

[1]  E. Wang,et al.  Rotavirus-associated diarrhea in outpatient settings and child care centers. The Greater Toronto Area/Peel Region PRESI Study Group. Pediatric Rotavirus Epidemiology Study for Immunization. , 2000, Archives of pediatrics & adolescent medicine.

[2]  I. Mutz,et al.  Distribution of Rotavirus VP4 Genotypes and VP7 Serotypes among Nonhospitalized and Hospitalized Patients with Gastroenteritis and Patients with Nosocomially Acquired Gastroenteritis in Austria , 2000, Journal of Clinical Microbiology.

[3]  A. Gervaix,et al.  [Rotavirus gastroenteritis in infants and children. Results of a prospective study in the area of Geneva and Basel 1997/1998 (RoMoS). RoMoS Study Group]. , 1999, Schweizerische medizinische Wochenschrift.

[4]  R. Glass,et al.  Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries. , 1999, Vaccine.

[5]  C. von Bonsdorff,et al.  Rotavirus gastroenteritis in Finland: burden of disease and epidemiological features , 1999, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[6]  D. Fleming,et al.  An estimate of the proportion of diarrhoeal disease episodes seen by general practitioners attributable to rotavirus in children under 5 y of age in England and Wales , 1999, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[7]  D. Brown,et al.  Seasonality and diversity of Group A rotaviruses in Europe , 1999, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[8]  U. Heininger,et al.  Rotavirus-Gastroenteritis im Säuglings- und Kleinkindesalter : Ergebnisse einer prospektiven Erfassung in den Regionen Genf und Basel 1997/1998 (RoMoS) , 1999 .

[9]  R. Holman,et al.  Hospitalizations associated with rotavirus diarrhea in the United States, 1993 through 1995: surveillance based on the new ICD-9-CM rotavirus-specific diagnostic code. , 1998, The Journal of infectious diseases.

[10]  R. Glass,et al.  Epidemiology of rotavirus diarrhoea in Africa: a review to assess the need for rotavirus immunization. , 1998, Bulletin of the World Health Organization.

[11]  X. Pang,et al.  Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis , 1997, The Lancet.

[12]  A. Kapikian,et al.  Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. , 1997, The New England journal of medicine.

[13]  L. Moulton,et al.  Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations. , 1997, The Journal of pediatrics.

[14]  C. Farrington,et al.  Hospital admissions attributable to rotavirus infection in England and Wales. , 1996, The Journal of infectious diseases.

[15]  R. Holman,et al.  The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of disease burden. , 1996, The Journal of infectious diseases.

[16]  R. Holman,et al.  Trends in hospitalizations for diarrhea in United States children from 1979 through 1992: estimates of the morbidity associated with rotavirus. , 1996, The Pediatric infectious disease journal.

[17]  R. Glass,et al.  Evaluation of Rhesus Rotavirus Monovalent and Tetravalent Reassortant Vaccines in US Children , 1995 .

[18]  R. Glass,et al.  Hospitalizations involving gastroenteritis in the United States, 1985: the special burden of the disease among the elderly. , 1992, American journal of epidemiology.

[19]  T. Vesikari,et al.  A Prospective Study of Acute Diarrhoea in Finnish Children from Birth to 2 1/2 Years of Age , 1991, Acta paediatrica Scandinavica.

[20]  R. Glass,et al.  Annual rotavirus epidemic patterns in North America. Results of a 5-year retrospective survey of 88 centers in Canada, Mexico, and the United States. Rotavirus Study Group. , 1990, JAMA.

[21]  S. MárquezCalderón,et al.  Incidence of diarrhea among groups of children in the city of Seville , 1990 .

[22]  S. Calderón,et al.  Incidencia de diarreas en una cohorte de niños en la ciudad de Sevilla , 1990 .

[23]  R. Glass,et al.  Global seasonality of rotavirus infections. , 1990, Bulletin of the World Health Organization.

[24]  T. Vesikari,et al.  Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. , 1990, Scandinavian journal of infectious diseases.

[25]  L. Brown,et al.  Comparison of a new rapid test (TestPack Rotavirus) with standard enzyme immunoassay and electron microscopy for the detection of rotavirus in symptomatic hospitalized children , 1989, Journal of clinical microbiology.

[26]  M. Gurwith,et al.  Gastroenteritis in Children: A Two-Year Review in Manitoba. I. Etiology , 1977, The Journal of infectious diseases.

[27]  D. Sackett,et al.  RANDOMISED CLINICAL TRIAL OF STRATEGIES FOR IMPROVING MEDICATION COMPLIANCE IN PRIMARY HYPERTENSION , 1975, The Lancet.